Madeline Repollet - ANGLE Plc Head Laboratories
| ANPCF Stock | USD 0.16 0.00 0.00% |
Insider
Madeline Repollet is Head Laboratories of ANGLE plc
| Phone | 44 14 8334 3434 |
| Web | https://angleplc.com |
ANGLE Plc Management Efficiency
The company has return on total asset (ROA) of (0.3011) % which means that it has lost $0.3011 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5577) %, meaning that it generated substantial loss on money invested by shareholders. ANGLE Plc's management efficiency ratios could be used to measure how well ANGLE Plc manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Hazeltine | Exagen Inc | 50 | |
| Ryan Douglas | Exagen Inc | N/A | |
| Salvatore Butera | Volitionrx | 73 | |
| Zhihong Zhang | Burning Rock Biotech | 48 | |
| Gary Pestano | Biodesix | 57 | |
| Cameron MBA | Volitionrx | 53 | |
| Shaokun Chuai | Burning Rock Biotech | 45 | |
| Ryan Siurek | Biodesix | 52 | |
| Jinxiang Li | Burning Rock Biotech | 39 | |
| Paul Beresford | Biodesix | N/A | |
| MD FACR | Exagen Inc | N/A | |
| Robert Cawthorn | Biodesix | 87 | |
| Heinrich Rder | Biodesix | N/A | |
| Gaetan Michel | Volitionrx | 51 | |
| Debra Zack | Exagen Inc | 65 | |
| Bobbi Coffin | Biodesix | N/A | |
| MingChou Lee | Exagen Inc | N/A | |
| Louise Day | Volitionrx | 53 | |
| Mark MBA | Volitionrx | 53 | |
| Nicholas Plummer | Volitionrx | 53 | |
| Dr III | Biodesix | 53 | |
Management Performance
| Return On Equity | -0.56 | |||
| Return On Asset | -0.3 |
ANGLE plc Leadership Team
Elected by the shareholders, the ANGLE Plc's board of directors comprises two types of representatives: ANGLE Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ANGLE. The board's role is to monitor ANGLE Plc's management team and ensure that shareholders' interests are well served. ANGLE Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ANGLE Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paul Smith, Chief Officer | ||
| Ian Griffiths, Finance Director, Company Secretary, Executive Director | ||
| Michael OBrien, Bus Director | ||
| AnneSophie PailhesJimenez, Head Ltd | ||
| Martin Cooke, Director Affairs | ||
| Andrew Holder, Head Relations | ||
| Madeline Repollet, Head Laboratories | ||
| Andrew Newland, Chief Executive, Executive Director |
ANGLE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is ANGLE Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.56 | |||
| Return On Asset | -0.3 | |||
| Operating Margin | (16.23) % | |||
| Current Valuation | 145.22 M | |||
| Shares Outstanding | 260.58 M | |||
| Shares Owned By Insiders | 10.75 % | |||
| Shares Owned By Institutions | 30.30 % | |||
| Price To Book | 3.48 X | |||
| Price To Sales | 144.24 X | |||
| Revenue | 1.01 M |
Currently Active Assets on Macroaxis
Other Information on Investing in ANGLE OTC Stock
ANGLE Plc financial ratios help investors to determine whether ANGLE OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ANGLE with respect to the benefits of owning ANGLE Plc security.